Evidence map›Paper›PMID 41934560›Full record

ArticleCardiovascular intervention and therapeutics2026

Insights from the assessment of anatomical valve orifice area after transcatheter aortic valve implantation using transesophageal echocardiography.

Kaho Shimada, Kai Ninomiya, Ryo Ninomiya, Akiko Murofushi, Shin Sato, Ryutaro Shimada, Wataru Numahata, Kengo Tosaka, Nozomu Kanehama, Michiko Yoshizawa and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cardiovascular intervention and therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kaho ShimadaDivision of Cardiology, Department of Internal Medicine, Iwate Medical University, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan.
Kai NinomiyaDivision of Cardiology, Department of Internal Medicine, Iwate Medical University, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan.
Ryo NinomiyaDivision of Cardiology, Department of Internal Medicine, Iwate Medical University, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan. rnino0123@gmail.com.ORCID http://orcid.org/0000-0003-1811-8501
Akiko MurofushiDivision of Cardiology, Department of Internal Medicine, Iwate Medical University, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan.
Shin SatoDivision of Cardiology, Department of Internal Medicine, Iwate Medical University, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan.
Ryutaro ShimadaDivision of Cardiology, Department of Internal Medicine, Iwate Medical University, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan.
Wataru NumahataDivision of Cardiology, Department of Internal Medicine, Iwate Medical University, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan.
Kengo TosakaDivision of Cardiology, Department of Internal Medicine, Iwate Medical University, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan.
Nozomu KanehamaDivision of Cardiology, Department of Internal Medicine, Iwate Medical University, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan.
Michiko YoshizawaDivision of Cardiology, Department of Internal Medicine, Iwate Medical University, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan.
Akiko KumagaiDivision of Cardiology, Department of Internal Medicine, Iwate Medical University, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan.
Tetsuya FusazakiDivision of Cardiology, Department of Internal Medicine, Iwate Medical University, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan.
Yoshihiro MorinoDivision of Cardiology, Department of Internal Medicine, Iwate Medical University, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan.

Funding

Abbott Japan Abbott JapanEdwards Lifesciences Edwards LifesciencesMedtronic Japan Medtronic Japan
6 · The paper itself

Abstract

Transthoracic echocardiography (TTE) is the gold standard for evaluating aortic valve function after transcatheter aortic valve implantation (TAVI). However, it is known that the Doppler method using TTE tends to overestimate the mean pressure gradient (mPG) and underestimate the effective orifice area (EOA), leaving room for debate regarding the most accurate method for assessing aortic valve function after TAVI. This study compared transesophageal echocardiography (TEE) and TTE measurements of transcatheter aortic valve (TAV) area and explored factors influencing the area difference. The anatomically derived valve orifice area index (AOA-i), traced from TEE images, was compared to the effective orifice area index (EOA-i) obtained from TTE. This study screened 493 consecutive patients who underwent SAPIEN 3 valve implantation, of whom 464 met the inclusion criteria. AOA-i was significantly larger than EOA-i, and the two showed only a weak correlation. By TTE, 42 cases (9.1%) had mPG ≥ 20 mmHg, and 37 cases (7.5%) satisfied moderate prosthesis–patient mismatch (PPM) criteria, but no severe PPM was observed. No difference in AOA-i was observed between patients with mPG ≥ 20 mmHg and those with mPG < 20 mmHg. Multivariate analysis showed that female, low stroke volume index, larger TAV size, and higher left ventricular mass index were independently associated with greater discrepancy between TTE and TEE measurements. This study demonstrated that TTE may overestimate hemodynamic parameters after TAVI, suggesting that TTE alone may not always accurately reflect true valve function. Multifaceted evaluation is considered essential for accurately assessing TAV function and making appropriate clinical decisions.

Indexed as

Aortic ValveAortic Valve StenosisEchocardiography, TransesophagealTranscatheter Aortic Valve ReplacementAgedAged, 80 and overFemaleHeart Valve ProsthesisHumansMaleRetrospective Studiesanatomical orifice areaeffective orifice areamean pressure gradientTAVItransesophageal echocardiography

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.